论文部分内容阅读
目的:探讨布地奈德联合沙丁胺醇雾化吸入在支气管哮喘急性发作治疗中的应用疗效。方法:选择我院收治的63例支气管哮喘急性发作患者随机分为对照组与研究组。其中,对照组的总例数为31例,给予该组患者沙丁胺醇雾化吸入治疗;研究组的总例数为32例,给予该组患者沙丁胺醇联合布地奈德雾化吸入治疗,分析比较两组患者的相关指标。结果:研究组哮鸣音消失的时间、胸闷、咳嗽、气短消失的时间比对照组优,且P<0.05,有统计学差异存在。结论:布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作患者,能取得确切的效果,建议临床应用与推广。
Objective: To investigate the efficacy of budesonide combined with salbutamol inhalation in the treatment of acute exacerbation of bronchial asthma. Methods: Sixty-three patients with acute bronchial asthma who were admitted to our hospital were randomly divided into control group and study group. Among them, the control group, the total number of cases was 31 cases, giving the group salbutamol inhalation therapy; the study group a total of 32 cases, giving the group salbutamol budesonide inhalation therapy, analysis and comparison of two groups Patient-related indicators. Results: The study group wheezing disappeared time, chest tightness, cough, shortness of breath shorter than the control group, and P <0.05, there is a statistically significant difference. Conclusion: Budesonide combined with salbutamol inhalation for the treatment of acute exacerbation of bronchial asthma patients can achieve the exact result, and its clinical application and promotion are suggested.